These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35844038)

  • 21. Pharmacokinetics and tolerability of intravenous ibuprofen injection in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study
.
    Zhou H; Xu W; Wu G; Wu L; Shentu J; Pan Z; Hu S; Liu Y
    Int J Clin Pharmacol Ther; 2016 Nov; 54(11):904-913. PubMed ID: 27569737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women.
    Lammerich A; Bias P; Gertz B
    Int J Womens Health; 2015; 7():707-16. PubMed ID: 26213478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study.
    Chen R; Fu R; Lin Z; Huang C; Huang W
    Lupus; 2023 Jan; 32(1):94-100. PubMed ID: 36416639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telitacicept following plasma exchange in the treatment of subjects with recurrent neuromyelitis optica spectrum disorders: A single-center, single-arm, open-label study.
    Ding J; Jiang X; Cai Y; Pan S; Deng Y; Gao M; Lin Y; Zhao N; Wang Z; Yu H; Qiu H; Jin Y; Xue J; Guo Q; Ni L; Zhang Y; Hao Y; Guan Y
    CNS Neurosci Ther; 2022 Oct; 28(10):1613-1623. PubMed ID: 35851754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic properties and safety profile of histamine dihydrochloride injection in Chinese healthy volunteers: a phase I, single-center, open-label, randomized study.
    Li J; Huang X; Wang Q; Jing S; Jiang H; Wei Z; Zang Y; Liu Y; Zhao L; Fang Y; Feng W
    Clin Ther; 2015 Oct; 37(10):2352-64. PubMed ID: 26276501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic Properties and Tolerability of Cycloserine Following Oral Administration in Healthy Chinese Volunteers: A Randomized, Open-Label, Single- and Multiple-Dose 3-Way Crossover Study.
    Zhou H; Wu G; Hu X; Zhu M; Zhai Y; Liu J; Shentu J; Wu L
    Clin Ther; 2015 Jun; 37(6):1292-300. PubMed ID: 25869627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-Compartmental Pharmacokinetics and Safety of Single-Dose Eldecalcitol (ED-71) in Healthy Chinese Adult Males.
    Zhao Q; Liu H; Jiang J; Wu Y; Zhong W; Li L; Miya K; Abe M; Hu P
    Clin Drug Investig; 2018 Oct; 38(10):901-908. PubMed ID: 30117129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses.
    Wu G; Zheng Y; Zhou H; Hu X; Liu J; Zhai Y; Zhu M; Wu L; Shentu J
    Drug Des Devel Ther; 2015; 9():5687-95. PubMed ID: 26527863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
    Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
    Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study.
    Chu NN; Huang K; Que LL; Ding Y; Gu XH; Zhang L; Wang JK; Chen XP; Sun ZG; He Q
    Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):509-521. PubMed ID: 35429285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study.
    Li H; Wei Y; Yang Z; Zhang S; Xu X; Shuai M; Vitse O; Wu Y; Baccara-Dinet MT; Zhang Y; Li J
    Am J Cardiovasc Drugs; 2020 Oct; 20(5):489-503. PubMed ID: 32080823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics, safety, and tolerability of GLPG0259, a mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5) inhibitor, given as single and multiple doses to healthy male subjects.
    Namour F; Vanhoutte FP; Beetens J; Blockhuys S; De Weer M; Wigerinck P
    Drugs R D; 2012 Sep; 12(3):141-63. PubMed ID: 22950522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Double-Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects.
    Hussaini A; Mukherjee R; Berdieva DM; Glogowski C; Mountfield R; Ho PTC
    Clin Transl Sci; 2020 Mar; 13(2):337-344. PubMed ID: 31664766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
    Taylor L; Gidal B; Blakey G; Tayo B; Morrison G
    CNS Drugs; 2018 Nov; 32(11):1053-1067. PubMed ID: 30374683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, Pharmacodynamics, and Safety of Dulaglutide After Single or Multiple Doses in Chinese Healthy Subjects and Patients with T2DM: A Randomized, Placebo-Controlled, Phase I Study.
    Xu J; Zhang Y; Li Y; Zhao X; Zhou W; Loghin C; Tham LS; Cui X; Cui Y; Wang W
    Adv Ther; 2022 Jan; 39(1):488-503. PubMed ID: 34787823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination treatment with telitacicept, mycophenolate mofetil and glucocorticoids for immunoglobulin A nephropathy: A case report.
    Shen Y; Yuan J; Chen S; Zhang YF; Yin L; Hong Q; Zha Y
    World J Clin Cases; 2024 Oct; 12(29):6307-6313. PubMed ID: 39417050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and Pharmacodynamics of Two Formulations of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Chinese Subjects: An Open-Label, Randomized, Parallel-Design Bioavailability Study.
    Hu C; Ji B; Hu X; Yang C; Sun W; Zhao X; Li L; Li X; Zhang L
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):291-298. PubMed ID: 32567217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A long-acting pegylated recombinant human growth hormone (Jintrolong
    Guan Y; He F; Wu J; Zhao L; Wang X; Huang L; Zeng G; Ren B; Chen J; Liao X; Ma Z; Chen X; Zhong G; Huang M; Zhao X
    J Clin Pharm Ther; 2018 Oct; 43(5):640-646. PubMed ID: 29959799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and safety of golimumab in healthy Chinese subjects following a single subcutaneous administration in a randomized phase I trial.
    Zhuang Y; Lyn S; Lv Y; Xu Z; Bouman-Thio E; Masterson T; Ford JA; Keen M; Petty KJ; Davis HM; Zhou H
    Clin Drug Investig; 2013 Nov; 33(11):795-800. PubMed ID: 23975656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single- and multiple-dose pharmacokinetics of genistein capsules in healthy chinese subjects: A phase I, randomized, open-label study.
    Zeng X; Feng Y; Yang L; Huang Y; Zhou D; Sun J; Liu Y; Deng Y
    Curr Ther Res Clin Exp; 2008 Aug; 69(4):318-33. PubMed ID: 24692809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.